TITAN PHARMACEUTICALS, INC.
Grant: $5,564,010 - National Institutes of Health - Sep. 30, 2009
No votes have been cast for this award yet
Join the conversation: Post a comment about this award
Award Description: We are conducting a six-month, randomized, placebo and active-controlled, multicenter clinical trial of Probuphine in patients with opioid dependence for the purpose of developing a new drug for the treatment of opioid dependence.
Project Description: Funds were awarded the day prior to the end of the reporting quarter. This is the first reporting quarter and no activities have occurred. Project has not started.
Jobs Summary: Grant was awarded on 09/30/2009 and the project has not started. (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Sep. 30, 2009. Help expand these official descriptions using the wiki below.
Funds from this award have been disbursed to sub-grantees. Click here to see a list of sub-grantees.
No comments have been added for this project.